Dyskalemia in people at increased risk for heart failure: findings from the heart ‘OMics’ in AGEing (HOMAGE) trial

AIMS: In people at risk of heart failure (HF) enrolled in the Heart ‘OMics’ in AGEing (HOMAGE) trial, spironolactone reduced circulating markers of collagen synthesis, natriuretic peptides, and blood pressure and improved cardiac structure and function. In the present report, we explored factors ass...

Descripción completa

Detalles Bibliográficos
Autores principales: Monzo, Luca, Ferreira, João Pedro, Cleland, John G.F., Pellicori, Pierpaolo, Mariottoni, Beatrice, Verdonschot, Job A.J., Hazebroek, Mark R., Collier, Tim J., Cuthbert, Joe J., Pieske, Burkert, Edelmann, Frank, Petutschnigg, Johannes, Khan, Javed, Ahmed, Fozia Z., Girerd, Nicolas, Bozec, Erwan, Díez, Javier, González, Arantxa, Clark, Andrew L., Cosmi, Franco, Staessen, Jan A., Heymans, Stephane, Rossignol, Patrick, Zannad, Faiez
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Short Communications
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773649/
https://www.ncbi.nlm.nih.gov/pubmed/36065795
http://dx.doi.org/10.1002/ehf2.14086

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9773649/
https://www.ncbi.nlm.nih.gov/pubmed/36065795
http://dx.doi.org/10.1002/ehf2.14086

Ejemplares similares